Provided by Tiger Trade Technology Pte. Ltd.

SeaStar Medical Holding Corporation

3.72
+0.530016.61%
Post-market: 3.70-0.0160-0.43%19:57 EDT
Volume:1.37M
Turnover:4.69M
Market Cap:16.39M
PE:-0.98
High:3.77
Open:3.26
Low:3.05
Close:3.19
52wk High:7.35
52wk Low:2.07
Shares:4.41M
Float Shares:4.27M
Volume Ratio:4.49
T/O Rate:32.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8118
EPS(LYR):-5.8608
ROE:-356.87%
ROA:-102.67%
PB:3.82
PE(LYR):-0.63

Loading ...

Top ICU Medical Executive Makes a Notable Move With Company Stock

TIPRANKS
·
Aug 13

SeaStar Medical Holding Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Harmonic Q2 Revenue Beats Estimates on Broadband Growth

Reuters
·
Aug 13

SeaStar Medical Q2 FY26 Net Loss Widens to $3.7 Million; Revenue Rises 82% to $0.6 Million

Reuters
·
Aug 13

SeaStar Medical Holding Q2 EPS $(0.91) Beats $(0.97) Estimate, Sales $615.000K Beat $486.500K Estimate

Benzinga Earnings
·
Aug 13

SeaStar Medical Q2 EPS USD -0.91

THOMSON REUTERS
·
Aug 13

Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
Aug 13

SeaStar Medical Holding Corp Expected to Post a Loss of 97 Cents a Share - Earnings Preview

Reuters
·
Aug 11

SeaStar Medical Holding Corp Expected to Post a Loss of 97 Cents a Share - Earnings Preview

Reuters
·
Aug 07

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

Benzinga Earnings
·
Aug 07

ICU Medical Price Target Raised to $187.00/Share from $165.00 by Needham

Dow Jones
·
Aug 07

ICU Medical Q2 2026 earnings: Organic revenue rises 6% as guidance increases

TradingKey
·
Aug 07

ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate

Benzinga Earnings
·
Aug 07

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance

GlobeNewswire
·
Aug 07

SeaStar Medical to Report Second-Quarter Results After Market Close, Host Webcast Call

Reuters
·
Aug 06

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

GlobeNewswire
·
Aug 06

SSY Group Wins NMPA Approvals for Four New Drugs, Bolsters Ophthalmic and ICU Portfolios

TIPRANKS
·
Aug 06

ICU Medical (ICUI) Could Be 2% Undervalued As Recall Questions Meet A Full P E

Simply Wall St.
·
Aug 03

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

GlobeNewswire
·
Jul 28

ICU Medical is Maintained at Overweight by Keybanc

Dow Jones
·
Jul 21